88 related articles for article (PubMed ID: 15523048)
1. Impact of transcription factor profile and chromatin conformation on human hepatocyte CYP3A gene expression.
Phillips A; Hood SR; Gibson GG; Plant NJ
Drug Metab Dispos; 2005 Feb; 33(2):233-42. PubMed ID: 15523048
[TBL] [Abstract][Full Text] [Related]
2. Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.
Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 1999 May; 289(2):1121-7. PubMed ID: 10215695
[TBL] [Abstract][Full Text] [Related]
3. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes.
Shenoy SD; Spencer TA; Mercer-Haines NA; Abdolalipour M; Wurster WL; Runge-Morris M; Kocarek TA
Mol Pharmacol; 2004 May; 65(5):1302-12. PubMed ID: 15102959
[TBL] [Abstract][Full Text] [Related]
4. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11.
Anakk S; Kalsotra A; Kikuta Y; Huang W; Zhang J; Staudinger JL; Moore DD; Strobel HW
Pharmacogenomics J; 2004; 4(2):91-101. PubMed ID: 14770174
[TBL] [Abstract][Full Text] [Related]
5. A novel female-specific member of the CYP3A gene subfamily in the mouse liver.
Sakuma T; Takai M; Endo Y; Kuroiwa M; Ohara A; Jarukamjorn K; Honma R; Nemoto N
Arch Biochem Biophys; 2000 May; 377(1):153-62. PubMed ID: 10775455
[TBL] [Abstract][Full Text] [Related]
6. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C.
Ding X; Staudinger JL
Biochem Pharmacol; 2005 Mar; 69(5):867-73. PubMed ID: 15710363
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytochromes P450 3A in mouse lung: effects of dexamethasone and pregnenolone 16alpha-carbonitrile.
Haag M; Fautrel A; Guillouzo A; Frossard N; Pons F
Arch Toxicol; 2003 Mar; 77(3):145-9. PubMed ID: 12632254
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression.
Vyhlidal CA; Gaedigk R; Leeder JS
Drug Metab Dispos; 2006 Jan; 34(1):131-7. PubMed ID: 16243958
[TBL] [Abstract][Full Text] [Related]
9. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
Matheny CJ; Ali RY; Yang X; Pollack GM
Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes.
Kostrubsky VE; Lewis LD; Strom SC; Wood SG; Schuetz EG; Schuetz JD; Sinclair PR; Wrighton SA; Sinclair JF
Arch Biochem Biophys; 1998 Jul; 355(2):131-6. PubMed ID: 9675018
[TBL] [Abstract][Full Text] [Related]
11. Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor.
Brobst DE; Ding X; Creech KL; Goodwin B; Kelley B; Staudinger JL
J Pharmacol Exp Ther; 2004 Aug; 310(2):528-35. PubMed ID: 15075359
[TBL] [Abstract][Full Text] [Related]
12. Induction of CYP3A by ethanol in multiple in vitro and in vivo models.
Feierman DE; Melinkov Z; Nanji AA
Alcohol Clin Exp Res; 2003 Jun; 27(6):981-8. PubMed ID: 12824820
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gender-dependent CYP2A expression in pigs: involvement of androgens and CAR.
Gillberg M; Skaanild MT; Friis C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):480-7. PubMed ID: 16635107
[TBL] [Abstract][Full Text] [Related]
14. Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture.
Greuet J; Pichard L; Ourlin JC; Bonfils C; Domergue J; Le Treut P; Maurel P
Hepatology; 1997 May; 25(5):1166-75. PubMed ID: 9141435
[TBL] [Abstract][Full Text] [Related]
15. Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats.
Konno Y; Sekimoto M; Nemoto K; Degawa M
Toxicol Appl Pharmacol; 2004 Apr; 196(1):20-8. PubMed ID: 15050404
[TBL] [Abstract][Full Text] [Related]
16. Insights into gender bias: rat cytochrome P450 3A9.
Anakk S; Ku CY; Vore M; Strobel HW
J Pharmacol Exp Ther; 2003 May; 305(2):703-9. PubMed ID: 12606633
[TBL] [Abstract][Full Text] [Related]
17. Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.
Nicoll-Griffith DA; Chauret N; Houle R; Day SH; D'Antoni M; Silva JM
Drug Metab Dispos; 2004 Dec; 32(12):1509-15. PubMed ID: 15550722
[TBL] [Abstract][Full Text] [Related]
18. Cyp3A regulation: from pharmacology to nuclear receptors.
Quattrochi LC; Guzelian PS
Drug Metab Dispos; 2001 May; 29(5):615-22. PubMed ID: 11302925
[TBL] [Abstract][Full Text] [Related]
19. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.
Lambert CB; Spire C; Claude N; Guillouzo A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):345-60. PubMed ID: 19084549
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
